Showing 1-10 of 48 grants

Title Institution Researcher Program Duration Total Award Amount
Building Organotypic Vascularized Pancreatic Islets with Real-Time 4D Tracking of Engraftment and Vascular Maturation The Regents of the University of California, Los Angeles Chen Yuan Kam Cures 01-April-2026 to 31-March-2027 $200.000,00
Do Islet Somatic Mutations Contribute to T1D Age at Onset? Beckman Research Institute of the City of Hope Melanie Shapiro Cures 01-March-2026 to 28-February-2027 $100.000,00
IL-37 expressing Treg cells to improve T1D therapeutic strategy University of California, San Diego Mayumi Fujita Cures 01-September-2025 to 28-February-2026 $161.904,81
Engineering Treg Signaling to Develop an Effective Cell Therapy for Type 1 Diabetes The Regents of the University of California, San Francisco Roberto Castro-Gutierrez Cures 01-March-2026 to 28-February-2029 $285.000,00
Optimized bone marrow conditioning and tolerance assays to advance cell-based therapies for diabetes Stanford University Stephan Ramos Cures 01-March-2026 to 28-February-2029 $285.000,00
Pseudohypoxia to improve SC-beta engraftment The Regents of the University of California, San Francisco Qizhi Tang Cures 01-October-2025 to 30-September-2027 $600.000,00
Combination therapy with STX4 activating small molecules or small activating RNA together with harmine to stimulate beta-cell regeneration and enhance functional beta-cell mass Beckman Research Institute of the City of Hope Debbie Thurmond Cures 01-October-2025 to 30-September-2028 $1.050.000,00
Broad Scope CMC, Non-Clinical, and Regulatory Support Dark Horse Consulting Nathan Manley Cures 01-September-2025 to 31-December-2026 $85.000,00
Brown University IND Readiness Gap Analysis Dark Horse Consulting Nathan Manley Cures 01-June-2025 to 31-December-2025 $87.770,00
Modulation of beta cell mRNA Translation in Type 1 Diabetes Beckman Research Institute of the City of Hope Farooq Syed Cures 01-September-2024 to 31-March-2027 $444.138,25